Merck to Acquire Indy Company in $780M Deal
A Hoosier biopharmaceutical contract development and manufacturing organization will soon be under new ownership. Germany-based Merck KGaA has announced plans to acquire Exelead, headquartered in Indianapolis, in a $780 million deal. Merck ... Read More